Selecting the First Market to Enter based on Certificates for Exports: MedTech Compliance in the EU, UK, and USA

 

Understanding the regulatory landscape is crucial when medical device manufacturers plan to enter international markets. Each major market—the EU, UK, and USA—has unique requirements and certification processes that ensure safety and compliance. Here’s a breakdown of the certificates from each region and factors to consider for the first market entry.

 

Certificate of Free Sale (CFS) - EU

In the European Union, a Certificate of Free Sale (CFS) is issued under Article 60 of the Medical Devices Regulation (MDR) 2017/745. This certificate verifies that a medical device complies with EU regulations and carries the CE marking, allowing it to be marketed within the EU and exported.

 

Key Features:

• Eligibility: Only manufacturers and authorised representatives within the EU.
• Documentation: Includes EU Declaration of Conformity, EC Certificates, and UDI-DI details.
• Acceptance: Widely accepted by many global markets for export.

 

Certificate of Free Sale (CFS) - UK

Following Brexit, the UK developed its framework for medical devices. The Medicines and Healthcare Products Regulatory Agency (MHRA) issues the CFS for devices that meet the UK Medical Devices Regulations 2002.

 

Key Features:

• Eligibility: UK-based manufacturers or authorised representatives in Northern Ireland.
• Marks: UKCA, CE, or CE UKNI marks are necessary.
• Validity: Specific to Great Britain, the entire UK, or the UK and EEA, depending on the conformity mark.

 

Export Certificates - USA

The USA issues various types of export certificates through the FDA, including the Certificate to Foreign Government (CFG) and Certificate of Exportability (COE), under different sections of the FD&C Act. These certificates are essential for products that aim to enter international markets from the US.

 

Key Features:

• Types: CFG for devices legally marketed in the US; COE for devices that meet specific export criteria but may not be marketed in the US.
• Eligibility: Must be registered with the FDA and comply with US regulations.
• Acceptance: Generally recognised by numerous global markets.

 

Selecting the First Market Entry: Factors to Consider

When deciding where to launch a medical device first, manufacturers should weigh several strategic factors:

1. Regulatory Complexity: Understand the regulatory requirements and the complexity of compliance in each market. For example, the EU's MDR is considered stringent, which might provide a robust compliance framework that could simplify entry into other markets.
2. Market Size and Access: Consider the potential market size and ease of access. The USA and EU are large markets with substantial healthcare spending, which can offer significant commercial opportunities.
3. Time and Cost of Certification: Assess the time and cost of obtaining the necessary certifications. For instance, the UK's process may be quicker post-Brexit, with potentially less backlog than the EU's system.
4. Legal and Regulatory Stability: Evaluate the stability and predictability of regulatory regimes. As Brexit has affected the UK’s regulatory landscape, regulatory changes can impact market strategies.
5. Local Presence Requirements: Some certifications, like the EU’s CFS, require a local authorised representative, which might necessitate establishing or partnering with local entities.
6. Global Recognition: Consider how widely each certificate is accepted internationally. Well-recognized certificates can facilitate easier entry into subsequent markets.
7. Strategic Importance: Some markets might hold strategic importance due to their technological advancement, leading healthcare facilities, or status as trendsetters in medical device innovation.

 

Choosing the first market for entry is a significant strategic decision that impacts a medical device's commercial trajectory. Manufacturers must carefully evaluate their readiness, the regulatory environment, and market potential when planning their international expansion strategies.

 

Med-Di-Dia specialises in regulatory affairs, quality compliance, and market access for medical devices, diagnostics, and digital health. We support manufacturers in many ways and always recommend that they engage early with RAQA experts to avoid regulatory oversight and maximise profits from the best markets suitable for their devices.

 

Regulatory Guidance and Compliance services offered by Med-Di-Dia

 

• 1. Understanding Regulatory Requirements: Med-Di-Dia can provide detailed guidance on regulatory requirements specific to different markets, such as the EU, UK, and USA. This includes assistance with understanding the nuances of the Medical Devices Regulation (MDR) in the EU, the FDA’s regulations in the USA, and the UK's post-Brexit regulatory landscape.
• 2. Certification Assistance: we can help manufacturers prepare the necessary documentation and ensure compliance to obtain certifications such as the Certificate of Free Sale (CFS) in the EU and UK and the various export certificates issued by the FDA.
• Quality Management Systems
• 3. Implementing Quality Systems: Med-Di-Dia can assist in setting up or enhancing Quality Management Systems (QMS) that meet international standards such as ISO 13485. A robust QMS is crucial not only for regulatory compliance but also for ensuring product safety and efficacy.
• 4. Audit Preparation: We can help prepare for audits conducted by regulatory bodies or external entities, ensuring that manufacturers meet all the required standards and regulations.
• 5. Market Access Strategy: Med-Di-Dia can provide strategic advice on market entry, including market size analysis, regulatory barriers, competitive landscape, and potential partnerships or local presence requirements.
• 6. Local Representation: In regions where having a local authorised representative is mandatory (like in the EU, UK, USA), Med-Di-Dia could potentially either act as a representative or help find a suitable partner.
• 7. Ongoing Regulatory Support: Providing continuous support to handle regulatory updates, re-certifications, and compliance checks as regulations evolve.
• 8.  Risk Management Planning: Assisting in developing comprehensive risk management plans to identify potential market entry risks and regulatory non-compliance risks.
• 9. Post-Market Activities: Help set up systems for post-market surveillance and vigilance to maintain compliance after the product is launched in new markets.

By partnering with Med-Di-Dia, manufacturers can navigate the regulatory complexities more efficiently and enhance their chances of successful market entry and sustained compliance. This support is essential in reducing the time to market, managing costs, and mitigating risks associated with global market access for medical devices.

 

Reach out to us by sending us an email at mdd@mddltd.com or by submitting a web form - https://med-di-dia.com/contact.php

Back...